Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06302777

MAIN-IMAGE Registry

All comers registry with patients with chronic coronary syndrome or acute coronary syndrome who underwent intracoronary imaging during cardiac catherization. The aim is to identify plaque characteristics on OCT or IVUS that are associated with adverse cardiac events including myocardial infarction and atherosclerotic progression.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Frankfurt University Hospital, Frankfurt am Main, Hesse, Germany

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients undergoing pre-intervention optical coherence tomography imaging

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. Major adverse cardiovascular Events (MACE)

    Time frame: after 2 years

Study contacts

Contact information is provided by the study sponsor or research team.

Lena Seegers, MD

CONTACT

[email protected]

+4963016666

Sponsors and collaborators

Lead sponsor

Goethe University

Other

Registry information

Official study title

Multifactorial Analysis of Coronary Artery Plaques Using INtracoronary IMAGing for Exploration of Atherosclerotic Determinants and Progression - the MAIN-IMAGE Registry

Acronym: MAIN-IMAGE

Important dates

Study start
2023
Primary completion
2028
Study completion
2031
First posted
Mar 12, 2024
Registry last updated
Mar 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.